A New Model of Primary Human Adipocytes Reveals Reduced Early Insulin Signalling in Type 2 Diabetes

Abstract

The aim of this study was to establish a diabetic model of primary human adipocytes for investigating potential defects in early insulin signalling. Specimens of human subcutaneous adipose tissue were obtained during orthopaedic surgical procedures. Preadipocytes were isolated and differentiated to adipocytes. Western blot analysis and immunoprecipitation were performed to determine protein content of IRS-1, IRS-2, p85, phosphorylation of IRS-1, IRS-2, Akt and MAPK as well as association between p85 and IRS-1/IRS-2. In addition to short-term insulin stimulation, the effect of hyperinsulinaemia was investigated by treating cells with insulin over a period of 36 hours. We found a significantly reduced basal expression of IRS-1 (54 ± 15 %) in adipocytes from type 2 diabetic subjects compared to controls with a further significant reduction in expression after long-term treatment (30 ± 12 %) compared to short-term treatment. IRS-2 expression also showed a significant reduction under hyperinsulinaemic conditions (20 ± 2 %) in diabetics vs. controls. Furthermore, long-term treatment with insulin in diabetic adipocytes led to a significant reduction in the phosphorylation of IRS-1(68 ± 11 %), IRS-2 (82 ± 11 %), Akt (42 ± 2 %), and MAPK (92 ± 12 %) and in the subsequent association between p85 to IRS-1 and IRS-2 (100 ± 16 % and 96 ± 12 %) in comparison to controls. Investigating glucose uptake diabetic adipocytes revealed a significant reduction of 90 ± 2 %. In this study, we were able to establish a new diabetic model of primary human adipocytes. A defect in early insulin signalling in type 2 diabetic patients under hyperinsulinaemic conditions was determined. These results might help to give further insights in early insulin action; additionally, this human model represents a useful target for the study of new therapeutic approaches.

Key words

Insulin action · Long-term insulin treatment · Insulin resistance · Human diabetic model · Primary cell culture

References

• 1 Sun X J. et al . Expression and function of IRS-1 in insulin signal transmission.  J Biol Chem. 1992;  267 22 662-22 672
• 2 Rothenburg P L. et al . Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase.  J Biol Chem. 1991;  266 8302-8311
• 3 Sun X J. et al . Role of IRS-2 in insulin and cytokine signalling.  Nature. 1995;  377 173-177
• 4 Antonetti D A, Algenstaedt P, Kahn C R. Insulin receptor substrate 1 bins two new splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain.  Mol Cell Biol. 1996;  16 2195-2203
• 5 Ueki K, Algenstaedt P, Mauvais-Jarvis F, Kahn C R. Positive and negative regulation of phosphoinostide 3-kinase-dependent signalling pathways by three different gene products of the p85alpha regulatory subunit.  Mol Cell Biol. 2000;  20 8035-8046
• 6 Folli F, Saad M J, Backer J M, Kahn C R. Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat.  J Biol Chem. 1992;  267 22171-22177
• 7 Shepherd P R, Nave B T, Siddle K. Insulin stimulation of glycogensynthase activity is blocked by wortmannin and rapamycin in 3T3L-1 adipocytes: evidence for the involvement of phophoinositide 3-kinase and p70 ribosomal protein-S6 kinase.  Biochem J. 1995;  271 1890-1897
• 8 Okada T, Kawano Y, Sahihara T, Hazeki O, Ui M. Essential role of phosphatidylinositol 3-kinase in insulin induced glucose transport and antilipolysis in rat adipocytes. Studies with selective inhibitor wortmannin.  J Biol Chem. 1994;  269 3568-3573
• 9 Czech M, Corvera S. Signaling mechanisms that regulate glucose transport.  J Biol Chem. 1999;  274 1865-1868
• 10 Wymann M P, Pirola L. Structure and function of phosphoinositide 3-kinases.  Biochem Biophys Acta. 1998;  1436 127-250
• 11 Virkamaki A, Ueki K, Kahn C R. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.  J Clin Invest. 1999;  103 931-943
• 12 Whiteman E L, Cho H, Birnbaum M J. Role of Akt/protein kinase B in metabolism.  TRENDS in Endocrinology and Metabolism. 2002;  13 444-451
• 13 Kahn C R. Insulin Receptors and Insulin Signaling in Normal and Disease States. International Textbook of Diabetes Mellitus, Second Edition. 1997: 437-466
• 14 Möhling M, Wegewitz U, Osterhoff M, Isken F, Ristow M. Insulin dereases human adiponectin plasma levels.  Horm Metab Res. 2002;  34 655-658
• 15 Kim S, Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte.  J Nutr. 2000;  130 3110S-3116S
• 16 Morrison R F, Farmer S R. Hormonal signalling and transcriptional control of adipocyte differentiation.  J Nutr. 2000;  130 3116S-3121S
• 17 Nadler S T, Stoehr J P, Rabaglia M E. et al . Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice.  Am J Physiol Endocrinol Metab. 2001;  281 E 1249-1254
• 18 Rondinone C M, Wang L M, Lonnroth P, Wesslau C, Pierce J H, Smith U. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus.  Proc Natl Acad Sci USA. 1997;  94 4171-4175
• 19 Araki E, Lipes M A, Patti M E, Bruning J C. et al . Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.  Nature. 1994;  372 186-190
• 20 Tamemoto H, Kadowaki T, Tobe K, Yagi T. et al . Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.  Nature. 1994;  372 182-186
• 21 Ricort J M, Tanti J F, Van Obberghen E, Le Marchand-Brustel Y. Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.  Diabetologia. 1995;  38 1148-1156
• 22 Pederson T M, Kramer D L, Rondinone C M. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation.  Diabetes. 2001;  50 24-31
• 23 Rice K M, Turnbow M A, Ganer C W. Insulin stimulates the degradation of IRS-1 in 3T3L-1 adipocytes.  Biochem And Biophys Res Commun. 1993;  190 961-967
• 24 Buren J, Liu H X, Lauritz J, Eriksson J W. High glucose and insulin in combination cause insulin receptor substrate-1 and -2 depletion and protein kinase B desensitisation in primary cultured rat adipocytes: possible implications for insulin resistance in type 2 diabetes.  Eur Endocrinol. 2003;  148 157-167
• 25 Nadler S T, Stoehr J P, Rabaglia M E. et al . Normal Akt/PKB with reduced PI3K activation in insulin-resistant mice.  Am J Physiol Endocrinol Metab. 2001;  281 E 1249-1254
• 26 Rojas F A, Hirata A E, Saad M J. Regulation of IRS-2 tyrosine phosphorylation in fasting and diabetes.  Mol Cell Endocrinol. 2001;  183 63-69
• 27 Rondinone C M, Carvalho E, Wesslau C, Smith U P. Impaired glucose transport and protein kinase B activation by insulin, but not okadaic acid, in adipocytes from subjects with Type II diabetes mellitus.  Diabetologia. 1999;  42 819-825